Sun Min Lim

Mahadi Baig: New Study Highlights Benefits of Subcutaneous Amivantamab with Lazertinib

Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC

Akhil Santhosh: Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-NSCLC

Stephen Liu: Perioperative osimertinib for resectable EGFR NSCLC

Hidehito Horinouchi: Early Career Investigator Workshop at WCLC24

Jarushka Naidoo: Phase II Lazertinib in EGFR+ NSCLC with CNS disease

5 articles suggested by Vivek Subbiah

Stephen V Liu: Join me in Singapore (or virtually) for WCLC23 on Saturday, September 9th